Medifast, Inc.
Medifast, Inc. (MED) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MED · as of Jun 8, 2026
Key Statistics
Explore Medifast, Inc. Data
med stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 33.3%
The MED analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing -0.83% downside from the current price of $12.10.
Competitors & Peers
med competitorsMED
AIIO
AKA
BSET
CAAS
CLARStock Performance
Full HistoryAbout Medifast, Inc.
Medifast, Inc. through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United State…
what is medifast, inc. · med stock overview · medifast, inc. company profile · who is medifast, inc. ceo · med NYSE · medifast, inc. headquarters · medifast, inc. business segments
About Stock Overview & Key Data
Medifast, Inc. (MED) is a Consumer Cyclical company in the Personal Products & Services industry, listed on NYSE since Dec 30, 1993. As of the latest trading session, MED stock price is $12.10, with a market capitalization of $134.5M. The stock has returned -8.75% over the past 12 months and +13.30% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Medifast, Inc. stock is Hold, with an average 12-month price target of $12.00. In fiscal year 2025, Medifast, Inc. reported revenue of $385.8M and net income of -$18.7M. For detailed data — including Medifast, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medifast, Inc. (MED) stock price is $12.10. The stock is traded on NYSE under the ticker symbol MED. The 52-week range is $9.22 – $15.46.